Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of atorvastatin on asthma control and airway inflammation in smokers with asthma
2006-003103-39Phase 2Completed
- Sponsor
- University of Glasgow
- Start
- Feb 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of atorvastatin in asthma (4 arms), sponsored by University of Glasgow. Primary endpoints: Morning peak expiratory flow improvement: atorvastatin vs placebo and Morning peak expiratory flow improvement: atorvastatin + inhaled corticosteroid vs atorvastatin + placebo. Started Feb 2008; status: completed.
02
Drugs
atorvastatin
03
Conditions
asthma
Beyond the preview
Go deeper on 2006-003103-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-003103-39.